(Q37826968)
Statements
1 reference
Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: Review of the evidence (English)
1 reference
1 reference
C Gridelli
1 reference
F De Marinis
1 reference
M Di Maio
1 reference
D Cortinovis
1 reference
T Mok
1 reference
8 January 2011
1 reference
1 reference
71
1 reference
3
1 reference
249-257
1 reference
Identifiers
1 reference
1 reference